2MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom; 3Oxford Centre for Molecular Sciences, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom; and 4Department of Biomedical Engineering/ND20, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195
Received on May 31, 2001; revised on August 31, 2001; accepted on August 31, 2001.
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: electrospray ionization mass spectrometry/fluorophore-assisted carbohydrate electrophoresis/hyaluronan/hyaluronidase/matrix-assisted laser desorption/ionization mass spectrometry.
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Though the above activities may all be due to HA, it is clearly essential that well-characterized and highly purified oligosaccharide preparations of defined size are used in both cell biological and structural studies so that erroneous results are avoided (Camenisch and McDonald, 2000). For instance, the pro-inflammatory effects of "low-molecular-weight HA" on interleukin-12 and tumor necrosis factor upregulation in monocytes, in fact, results from contaminating DNA (Filion and Phillips, 2001
). Furthermore, production of HA oligomers free from chondroitin sulfate has been shown recently to be of importance in establishing the role of HA in the accumulation of malaria parasiteinfected erythrocytes in placenta (Beeson et al., 2000
; Chai et al., 2001
).
Various methods for the production of HA oligomers have been described. Most of these involve the digestion of polymeric HA with the endohydrolase, testicular hyaluronidase, followed by purification by size exclusion chromatrography (Hardingham and Muir, 1973; Hascall and Heinegård, 1974
; Tammi et al., 1998
; Lesley et al., 2000
) and/or ion exchange chromatography (Holmbeck and Lerner, 1993
; Toffanin et al., 1993
; Almond et al., 1998
; Tammi et al., 1998
; Chai et al., 2001
), or by reverse-phase ion-pair high-performance liquid chromatography (HPLC) (Cramer and Bailey, 1991
). These methods result in even-numbered oligosaccharides for which the minimal size is HA4 (i.e., 2 disaccharide units in length). The use of hyaluronate lyase (Price et al., 1997
; Chai et al., 2001
) and sonication (Kubo et al., 1993
) have also been described; digestion with the former generates a modified unsaturated uronic acid moiety on the nonreducing termini and, therefore, is best avoided.
A range of techniques has been employed to assess the sizes of the oligomers produced. These were originally determined from the ratio of total glucuronic acid (GlcUA) concentration to that of the reducing end N-acetyl glucosamime (GlcNAc) group (Hardingham and Muir, 1973; Cramer and Bailey, 1991
) or the nonreducing terminal GlcUA (Hascall and Heinegård, 1974
). However, other methods, including capillary electrophoresis (Grimshaw, 1997
; Hong et al., 1998
), high pH anion-exchange chromatography (Lauder et al., 2000
), mass spectrometry (Price et al., 1997
; Schiller et al., 1999
; Yeung and Marecak, 1999
; Chai et al., 2001
) and nuclear magnetic resonance spectroscopy (Chai et al., 2001
), have more recently been employed. Many of the methods used have provided little information on the purity of the oligomer preparations and have limited capabilities to determine the molecular masses of longer oligosaccharides (i.e., greater than
HA16). In addition, apart from notable exceptions (Holmbeck and Lerner, 1993
; Lesley et al., 2000
), there have been few attempts to purify oligomers of greater than about HA20.
Here we describe the purification of HA oligosaccharides ranging from HA4 to HA34, including novel 5-mer and 7-mer species with terminal GlcUA groups, using size exclusion chromatography and ion-exchange HPLC. Oligomers were characterized using a combination of electrospray ionization mass spectrometry (ESI-MS), matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and fluorophore-assisted carbohydrate electrophoresis (FACE).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
|
|
|
Purification of high-molecular-weight HA oligomers
Polymeric HA was digested for 5 min to generate longer oligosaccharides (see Figure 1). These were fractionated by gel filtration on a Waters Protein PAK-125 column (data not shown), and the eluent from 12 to 20 min was collected and pooled (pool B). Oligosaccharides in pool B were subsequently purified by anion-exchange HPLC using gradient P2 (see Figure 5); this gradient was adapted from that used previously (i.e., P1) to give greater resolution of high-molecular-weight oligosaccharides. As can be seen from Figure 5 a wide range of oligomer lengths can be separated (from HA8, or less, to greater than HA34). However, the yield of each individual species is relatively low (12% of starting material for HA12 to HA24 and 0.5% of starting material for HA34).
|
Analysis of HA oligomers by MALDI-TOF MS
We evaluated several matrices for the analysis of HA oligosaccharides by MALDI-TOF MS. These included 2,5-dihydroxybenzoic acid, which has been used recently for the analysis of HA oligomers (Schiller et al., 1999; Yeung and Marecak, 1999
), but this matrix did not generate good signals. However, high-quality spectra were seen with a co-matrix of 2,4,6-trihydroxyacetophenone with triammonium citrate (Jovanovic et al., 2000
). In the positive ion mass spectra, the major species were generally a mixture of metal ion adducts, such as [M+Na]+ and [M+K]+, whereas [M-H] was the predominant species in the negative ion mode. Consequently, negative ion spectra were recorded in most cases, because they were easier to interpret, particularly for complex samples. Figure 6 shows a typical negative ion spectrum, which was obtained for peak 16 purified from pool B by anion-exchange HPLC (see Figure 5). Species consistent with the masses for the monovalent anions of HA30, HA32, and HA34 were observed. Additional peaks were also seen at +62 Da for HA32 and HA34, and these probably correspond to copper ion adducts, which are likely to be artifacts of the target used. Table II summarizes the results obtained for other peaks from anion-exchange chromatography (Figure 5) analyzed by MALDI-TOF MS. As shown in the table, the experimental masses obtained are in reasonable agreement with the theoretical molecular weights; any slight differences are believed to arise from the method of calibration. The results presented here demonstrate that MALDI-TOF MS is suitable for the analysis of a wide range of HA oligosaccharide sizes. In addition, MS analyses indicate that the HA oligomers produced here are of high purity. This was further investigated by FACE analysis.
|
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
For this reason we investigated MALDI-TOF MS for the analysis of higher-molecular-weight sugars. The use of this technique has been reported recently for HA4 to HA8 (Schiller et al., 1999) and for polydispersed mixtures of high molecular weight HA oligomers (Yeung and Marecak, 1999
), both of which were performed with matrices based on 2,5-dihydroxybenzoic acid. In our study this matrix gave poor results. However, good spectra were achieved with a co-matrix of 2,4,6-trihydroxyacetophenone and triammonium citrate for a wide range of oligomer sizes (i.e., HA8 to HA34). This co-matrix has been used previously for acidic oligosaccharides (Jovanovic et al., 2000
). It is expected that HA oligomers of considerably higher molecular weight could be analyzed in this way as we see excellent signal to noise for the largest HA species (34-mers) made here (as shown in Figure 6).
FACE has recently been developed for the characterization of HA and other glycosaminoglycans (Calabro et al., 2000a,b). This technique allows the sizing of HA oligomers from tetrasaccharides to greater than 50-mers. For low-molecular-weight HA species (HA4 to
HA20) the size can be determined relative to sugar standards (Figure 7). Longer HA molecules can be identified by indexing the gel with a HA oligomer of known size. In our case, HA22, characterized by ESI-MS, was used (see Figure 8). In general, MALDI-TOF MS, which can size longer oligomers than ESI-MS, would be an excellent way to calibrate HA standards for use in FACE analysis. Although, the results from MS and FACE analysis were in good general agreement, the latter method has the advantage of being able to quantitate the levels of minor species present. The HA6 preparation, for example, was found to contain 1% of chondroitin sulfate oligosaccharides (see Figure 7). Peak 16, on the other hand, though it contained no detectable chondroitin sulfate, was shown to be a mixture of HA34 (87%), HA32 (10%), and HA30 (3%). These species were also seen in MALDI-TOF MS, but this technique gave different values for their relative amounts (50%, 42% and 8%, respectively; Table II). It seems likely that this discrepancy results from an over estimation by MALDI-TOF MS of shorter oligomers (i.e., less charged species), due to their preferential desorption from the matrix.
The purification methods employed here allowed the production of a wide range of HA oligosaccharide sizes (HA4 to HA34). The low-molecular-weight oligomers (HA4 to HA16 purified with the P1 gradient) were homogenous with regard to length. These included saturated 5- and 7-mers, with terminal GlcUA residues, that to our knowledge have not been reported previously; the HA5 and HA7 species produced by digestion of HA with hyaluronate lyase (Price et al., 1997) also had terminal GlcUA residues, but these species were 18 Da smaller than those we have isolated, indicating that they contained an unsaturated sugar at their nonreducing end. It seems likely that the 5-mer and 7-mer we have identified result from a contaminating hydrolase enzyme in the ovine testicular hyaluronidase preparation used here.
There have been few previous attempts to purify and characterize HA oligosaccharides larger than 20-mers (Holmbeck and Lerner, 1993
; Lesley et al., 2000
). Here we have produced oligomers up to HA34 and the methodology used, we believe, could be extended (by adjusting digestion times and enzyme to substrate ratios) to prepare still longer molecules. As described above, peaks 7 to 16 were mixtures of HA of different lengths (see Figure 5) where the number of species present in a given sample were similar to those reported previously by Lesley et al. (2000)
; higher purity might be achieved by re-running the samples on the ion exchange column. The high-molecular-weight oligomers made here are proving useful in the investigation of multimeric protein-HA interactions (Mahoney and Day, unpublished data).
The high-molecular-weight HA preparations (HA22 to HA34) showed no detectable chondroitin sulfate (by FACE analysis). The low-molecular-weight HA oligosaccharides, however, contained significant amounts of this glycosaminoglycan. For instance, there was between 1% and 5% chondroitin sulfate in HA4 to HA10, whereas HA12, HA14, and HA16 contained 7%, 12%, and 15%, respectively. Oligomers of chondroitin sulfate were not identified in any of these samples by MS. This is perhaps not surprising given their low levels, as determined by FACE, with less than 10% in HA4-HA12, and the fact that such oligosaccharides were present as two species of similar intensity in HA14 and HA16 (see Figure 7). In addition, ESI-MS on 6- and 8-mers of chondroitin-4-sulfate (provided by T. E. Hardingham), performed in the negative ion mode under identical conditions to that reported here for HA, indicates that there is significant but partial desulfation of these oligomers even at low cone voltages (data not shown). Therefore, individual chondroitin sulfate species would be difficult to detect by ESI-MS at the levels seen here.
With hindsight chondroitin sulfate contaminants could have been avoided by the use of medical-grade or bacterial HA, which contain very low levels of chondroitin sulfate, rather than the relatively impure preparation from human umbilical cord. In this regard, suitable starting materials could be identified by FACE analysis of chondroitinase digests. In addition, HA preparations should be treated with deoxyribonuclease 1 to remove DNA contaminants (Filion and Phillips, 2001).
Clearly, it is of great importance to detect and quantify such contaminants because they could lead to erroneous results in biological assays (Camenisch and McDonald, 2000). The methodologies described here for the characterization of HA oligosaccharides by MS and FACE can be used to ensure the purity of these important reagents.
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Digestion of HA
HA (100 mg) was dissolved at a concentration of 3.33 mg/ml (30 ml total) in digest buffer (0.15 M NaCl, 0.1 M Na-acetate, adjusted to pH 5.2 with glacial acetic acid) and incubated at 37°C for 30 min. To this, ovine testicular hyaluronidase (0.22 mg; 11,000 U in 10 ml digest buffer) was added, and the solution incubated at 37°C. The digest was assessed at various time points by running 100 µl of the reaction mixture (diluted to 3.5 ml with H2O) on a 75 x 7.5 mm Waters PAK DEAE-5PW anion-exchange column, equilibrated in 5.0 mM ammonium hydrogen carbonate (buffer A) at a flow rate of 1 ml/min. The initial conditions were maintained for 10 min, and HA oligosaccharides were eluted with gradients of 050% and 5095% of buffer B (500 mM ammonium hydrogen carbonate) in buffer A over 15 and 5 min, respectively. Final conditions were maintained for 5 min prior to re-equilibration into buffer A. The eluent was monitored at 210 nm. When the reaction reached the desired point it was stopped by boiling for 5 min, dialyzed against 3 x 10 L H2O for 6 h each at 4°C, lyophilized, and stored at 20°C.
Size exclusion chromatography
The lyophilized reaction mixture from a 1 h digest was resuspended at 100 mg/ml in 0.2 M ammonium acetate and centrifuged (12,000 x g, 2 min) to remove any particulate material. Oligomers were then fractionated by size exclusion chromatography on a 36 x 2.5 cm Bio-Gel P-6 column equilibrated in 0.2 M ammonium acetate at a flow rate of 0.2 ml/min. The eluent was constantly monitored at 214 nm, and 1-ml fractions were collected from 25 to 80 min.
The 5-min digests were resuspended in 20 mM Na-acetate and 100 mM NaCl, purified on a 30 x 0.8 cm Protein PAK-125 column (Waters) equilibrated in the resuspension buffer, and run at 1.0 ml/min. The eluent (monitored at 210 nm) from 12 to 20 min was collected.
Size exclusion fractions were analyzed by running 100 µl on the anion-exchange column, as described in Digestion of HA except that oligomers were eluted with gradients of 050% and 5095% buffer B in A over 40 and 5 min, respectively (denoted here as gradient P1). Fractions containing the desired HA oligomers (as determined by MS) were then pooled, dialyzed extensively against H2O, lyophilized, and resuspended (at 2 mg/ml) in 5 mM ammonium hydrogen carbonate.
Preparative anion-exchange HPLC
Pools resulting from the Bio-Gel P-6 and Protein PAK-125 columns were then further purified by anion-exchange chromatography. For material resulting from the former column the P1 gradient was used, whereas in the latter case, a different elution gradient (P2: 035%, 3580%, and 8095% buffer B in A over 5, 45, and 5 min, respectively) was employed. Peaks were collected manually, pooled according to their elution position, and lyophilized. These samples were then resuspended in water and relyophilized twice to remove the buffer. The uronic acid content for each oligosaccharide was then determined by the metahydroxybiphenyl reaction (Blumenkrantz and Asboe-Hansen, 1973) as described previously (Kahmann et al., 2000
).
ESI-MS
HA oligosaccharides were analyzed by ESI-MS on a BIO-QII-ZS spectrometer (Micromass UK) run in the negative ion mode. The instrument was calibrated with bovine ubiquitin (12 pmol/µl; average molecular mass 8564.85 Da) and scanned over the mass range 200 to 900 Da. A typical sample had a concentration of about 5 pmol/µl and was run in 50% (v/v) acetonitrile and 0.5 mM ammonium acetate. A cone voltage of between 10 V and 35 V was used (depending on the length of the oligosaccharide), with a capillary voltage of 3.25 kV, a source block temperature of 40°C and a desolvation temperature of 120°C. Samples were admitted at a flow rate of 5 µl/min via a syringe pump (Harvard Model 11).
MALDI-TOF MS
MALDI-TOF MS analyses of HA oligosaccharides were done on a TofSpec 2E instrument (Micromass UK) in the reflectron mode. The spectrometer was calibrated using a mixture of angiotensin I (MH+ = 1296.7 Da) and adrenocorticocotrophic hormone amino acids 1839 (MH+ = 2466.2 Da) at 5 pmol/µl in an -cyano-4-hydroxycinnamic acid matrix (10 mg/ml in 30% [v/v] methyl cyanide and 0.1% [v/v] trifluoroacetic acid in water) and scanned over a mass range of 010,000 Da. The MALDI matrix was prepared using 2,4,6trihydroxyacetophenone and triammonium citrate (Jovanovic et al., 2000
). In brief, 1.2 µl of a mixture of equal volumes of 20 mg/ml 2,4,6-trihydroxyacetophenone in ethanol and aqueous 20 mM triammonium citrate was deposited onto the stainless steel target and air-dried. To this was added 1.2 µl of sample solution (
3 pmol/µl in 50% [v/v] acetonitrile) and allowed to dry. Both positive and negative mass spectra were recorded using the minimum laser energy required to give an observable signal (
10:1 signal:noise).
FACE
FACE analysis of HA oligosacccharides was done as described previously (Calabro et al., 2000a,b). Briefly, 50 nmol (or less) of test oligosaccharides and standards (Calabro et al., 2000b
) were lyophilized and derivatized by addition of 40 µl of 12.5 mM AMAC in 85% (v/v) dimethyl sulfoxide/15% (v/v) acetic acid followed by incubation for 15 min at room temperature. Then 40 µl of 1.25 M sodium cyanoborohydride in ultrapure water was added followed by incubation for 16 h at 37°C. After derivatization, 20 µl of glycerol was added to each sample prior to electrophoresis (of 5-µl aliquots) on MONO composition gels. These were run and analyzed as described elsewhere (Calabro et al., 2000b
). Briefly, the gels are illuminated with UV light (365 nm) from an Ultra Lum Transilluminator and imaged with a Quantix cooled CCD camera from Roper Scientific/Photometrics. Digital images for each gel are taken at two exposures. One exposure oversaturates pixel intensity for the major derivatized structures to allow visualization of less abundant species. The second exposure has all pixels within linear 12-bit depth range and is used for quantification. The images are analyzed using the Gel-Pro Analyzer program version 3.0 (Media Cybernetics).
Portions of each oligosaccharide preparation were also analyzed following digestion with Streptococcal hyaluronidase (type VI-S) and chondroitinase ABC lyase to produce disaccharides (see Calabro et al., 2000a). Briefly, samples were digested for 1 h at 37°C with hyaluronidase (1000 U/ml) followed by 3 h at 37°C with the addition of chondroitinase ABC (100 mU/ml). Digests were then immediately frozen on dry ice and lyophilized until dry on a vacuum concentrator prior to derivatization for FACE analysis.
![]() |
Acknowledgments |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Abbreviations |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Footnotes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Beeson, J.G., Rogerson, S.J., Cooke, B.M., Reeder, J.C., Chai, W., Lawson, A.M., Molyneux, M.E., and Brown, G.V. (2000) Adhesion of plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat. Med., 6, 8690.[ISI][Medline]
Bertrand, P. and Delpech, B. (1985) Interaction of hyaluronectin with hyaluronic acid oligosaccharides. J. Neurochem., 45, 434439.[ISI][Medline]
Blumenkrantz, N. and Asboe-Hansen, G. (1973) New method for quantitative determination of uronic acids. Anal. Biochem., 54, 484489.[ISI][Medline]
Calabro, A., Benavides, M., Tammi, M., Hascall, V.C., and Midura, R.J. (2000a) Microanalysis of enzyme digests of hyaluronan and chondroitin/dermatan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE). Glycobiology, 10, 273281.
Calabro, A., Hascall, V.C., and Midura, R.J. (2000b) Adaptation of FACE methodology for microanalysis of total hyaluronan and chondroitin sulfate composition from cartilage. Glycobiology, 10, 283293.
Camenisch, T.D. and McDonald, J.A. (2000) Hyaluronan. Is bigger better? Am. J. Respir. Cell Mol. Biol., 23, 431433.
Chai, W., Beeson, J.G., Kogelberg, H., Brown, G.V., and Lawson, A.M. (2001) Inhibition of adhesion of plasmodium falciparum-infected erythrocytes by structurally defined hyaluronic acid dodecasaccharides. Infect. Immun., 69, 420425.
Cramer, J.A. and Bailey, L.C. (1991) A reversed-phase ion-pair high-performance liquid chromatography method for bovine testicular hyaluronidase digests using postcolumn derivatization with 2-cyanoacetamide and ultraviolet detection. Anal. Biochem., 196, 183191.[ISI][Medline]
Day, A.J. (1999) The structure and regulation of hyaluronan-binding proteins. Biochem. Soc. Trans, 27, 115121.[ISI][Medline]
Day, A.J. (2001) Understanding hyaluronan-proteins interactions. Online document available at www.glycoforum.gr.jp/science/hyaluronan/HA16/HA16E.html.
Filion, M.C. and Phillips, N.C. (2001) Pro-inflammatory activity of contaminating DNA in hyaluronic acid preparations. J. Pharm. Pharmacol., 53, 555561.[ISI][Medline]
Fitzgerald, K.A., Bowie, A.G., Skeffington, B.S., and ONeill, L.A. (2000) Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells. J. Immunol., 164, 20532063.
Grimshaw, J. (1997) Analysis of glycosaminoglycans and their oligosaccharide fragments by capillary electrophoresis. Electrophoresis, 18, 24082414.[ISI][Medline]
Hardingham, T.E. and Muir, H. (1973) Binding of oligosaccharides of hyaluronic acid to proteoglycans. Biochem. J., 135, 905908.[ISI][Medline]
Hascall, V.C. and Heinegård, D. (1974) Aggregation of cartilage proteoglycans. II. Oligosaccharide competitors of the proteoglycan-hyaluronic acid interaction. J. Biol. Chem., 249, 42424249.
Holmbeck, S. and Lerner, L. (1993) Separation of hyaluronan oligosaccharides by the use of anion-exchange HPLC. Carbohydr. Res., 239, 239244.[ISI][Medline]
Hong, M., Sudor, J., Stefansson, M., and Novotny, M.V. (1998) High-resolution studies of hyaluronic acid mixtures through capillary gel electrophoresis. Anal. Chem., 70, 568573.[ISI]
Horton, M.R., Shapiro, S., Bao, C., Lowenstein, C.J., and Noble, P.W. (1999) Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J. Immunol., 162, 41714176.
Jovanovic, M., Konig, S., and Peter-Katalinic, P. (2000) Applicability of MALDI-PSD in negative mode for analysis of oligosaccharides, N-glycans and O-glycosylated amino acids. Paper presented at 48th ASMS Conference on Mass Spectometry and Allied Topics, Palm Beach, FL.
Kahmann, J.D., OBrien, R., Werner, J.M., Heinegard, D., Ladbury, J.E., Campbell, I.D., and Day, A.J. (2000) Localization and characterization of the hyaluronan-binding site on the link module from human TSG-6. Structure Fold. Des., 8, 763774.[ISI][Medline]
Kubo, K., Nakamura, T., Takagaki, K., Yoshida, Y., and Endo, M. (1993) Depolymerization of hyaluronan by sonication. Glycoconj. J., 10, 435439.[ISI][Medline]
Lauder, R.M., Huckerby, T.N., and Nieduszynski, I.A. (2000) A fingerprinting method for chondroitin/dermatan sulfate and hyaluronan oligosaccharides. Glycobiology, 10, 393401.
Lesley, J., Hascall, V.C., Tammi, M., and Hyman, R. (2000) Hyaluronan binding by cell surface CD44. J. Biol. Chem., 275, 2696726975.
Mahoney, D.J., Blundell, C.D., and Day, A.J. (2001) Mapping the hyaluronan-binding site on the link module from human tumor necrosis factor-stimulated gene-6 by site-directed mutagenesis. J. Biol. Chem., 276, 2276422771.
McKee, C.M., Penno, M.B., Cowman, M., Burdick, M.D., Strieter, R.M., Bao, C., and Noble, P.W. (1996) Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest., 98, 24032413.
Noble, P.W., McKee, C.M., Cowman, M., and Shin, H.S. (1996) Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J. Exp. Med., 183, 23732378.[Abstract]
Oertli, B., Beck-Schimmer, B., Fan, X., and Wuthrich, R.P. (1998) Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1. J. Immunol., 161, 34313437.
Ohkawara, Y., Tamura, G., Iwasaki, T., Tanaka, A., Kikuchi, T., and Shirato, K. (2000) Activation and transforming growth factor-beta production in eosinophils by hyaluronan. Am. J. Respir. Cell Mol. Biol., 23, 444451.
Price, K.N., Al, T., Baker, D.C., Chisena, C., and Cysyk, R.L. (1997) Isolation and characterization by electrospray-ionization mass spectrometry and high-performance anion-exchange chromatography of oligosaccharides derived from hyaluronic acid by hyaluronate lyase digestion: observation of some heretofore unobserved oligosaccharides that contain an odd number of units. Carbohydr. Res., 303, 303311.[ISI][Medline]
Rahmanian, M., Pertoft, H., Kanda, S., Christofferson, R., Claesson-Welsh, L., and Heldin, P. (1997) Hyaluronan oligosaccharides induce tube formation of a brain endothelial cell line in vitro. Exp. Cell Res., 237, 223230.[ISI][Medline]
Schiller, J., Arnhold, J., Benard, S., Reichl, S., and Arnold, K. (1999) Cartilage degradation by hyaluronate lyase and chondroitin ABC lyase: a MALDI-TOF mass spectrometric study. Carbohydr. Res., 318, 116122.[ISI][Medline]
Tammi, R., MacCallum, D., Hascall, V.C., Pienimäki, J.P., Hyttinen, M., and Tammi, M. (1998) Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J. Biol. Chem., 273, 2887828888.
Toffanin, R., Kvam, B.J., Flaibani, A., Atzori, M., Biviano, F., and Paoletti, A. (1993) NMR studies of oligosaccharides derived from hyaluronate: complete assignment of 1H and 13C NMR spectra of aqueous di- and tetra-saccharides, and comparison of chemical shifts for oligosaccharides of increasing degree of polymerisation. Carbohydr. Res., 245, 113128.[ISI][Medline]
Toole, B.P. (2000) Hyaluronan is not just a goo! J. Clin. Invest., 106, 335336.
Weissman, B. and Meyer, K. (1954) The structure of hyalobiuronic acid and hyaluronic acid from umbilical cord. J. Am. Chem. Soc., 76, 17531757.[ISI]
West, D.C., Hampson, I.N., Arnold, F., and Kumar, S. (1985) Angiogenesis induced by degradation products of hyaluronic acid. Science, 228, 13241326.[ISI][Medline]
Yeung, B. and Marecak, D. (1999) Molecular weight determination of hyaluronic acid by gel filtration chromatography coupled to matrix-assisted laser desorption ionization mass spectrometry. J. Chromatogr. A, 852, 573581.[ISI]
Zeng, C., Toole, B.P., Kinney, S.D., Kuo, J.W., and Stamenkovic, I. (1998) Inhibition of tumor growth in vivo by hyaluronan oligomers. Int. J. Cancer, 77, 396401.[ISI][Medline]